Ryght

Ryght, Inc. aims to leverage generative artificial intelligence for real-time biopharmaceutical discovery. The company’s platform fine-tunes large language models designed for real-time data, with verified and secure customer data storage specifically tailored to the needs of life sciences companies, enabling pharmaceutical companies to provide discovery, clinical, and commercial teams with unprecedented, actionable knowledge.